The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
amgen | 8352 |
amgen fremont | 232 |
medarex | 180 |
amgen research (munich) | 156 |
kirin-amgen | 123 |
pfizer | 115 |
u3 pharma | 112 |
cytokinetics | 75 |
ucb pharma | 55 |
boehringer ingelheim international | 49 |
amgen | 789 |
amgen fremont | 17 |
medarex | 11 |
pfizer | 10 |
biovitrum | 7 |
biovex | 7 |
epix pharmaceuticals | 6 |
u3 pharma | 6 |
cytokinetics | 5 |
alantos pharmaceuticals holding | 5 |
amgen | 723 |
amgen research (munich) | 37 |
amgen fremont | 25 |
kirin-amgen | 19 |
daiichi sankyo europe | 16 |
pfizer | 13 |
cytokinetics | 11 |
medimmune | 11 |
novo nordisk | 11 |
teijin pharma | 10 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) | 124 | 2007 |
sclerostin binding agents | 121 | 2005 |
il-17 receptor a antigen binding proteins | 80 | 2006 |
human monoclonal antibodies to activin receptor-like kinase-1 | 74 | 2005 |
piperidinone derivatives as mdm2 inhibitors for the treatment of cancer | 73 | 2010 |
human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors | 69 | 2003 |
variant activin receptor polypeptides and uses thereof | 67 | 2007 |
alpha-4-beta-7 heterodimer specific antagonist antibody | 66 | 2009 |
variants of activin iib receptor polypeptides and uses thereof | 64 | 2008 |
therapeutic human anti-il-1r1 monoclonal antibody | 64 | 2002 |